Dicerna Pharmaceuticals
Why Robinhood?
You can watch DRNA and buy or sell other stocks, ETFs, and their options commission-free!About DRNA
Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. It uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas.
DRNA Key Statistics
Stock Snapshot
The current Dicerna Pharmaceuticals(DRNA) stock price is $38.22, with a market capitalization of 2.98B. The stock trades at a price-to-earnings (P/E) ratio of -23.44.
Dicerna Pharmaceuticals(DRNA) stock opened on 2026-03-14 at —. The price climbed to — and dipped to —.
Dicerna Pharmaceuticals(DRNA) shares are trading with a volume of 0, against a daily average of 3.2M.
In the last year, Dicerna Pharmaceuticals(DRNA) shares hit a 52-week high of $40.14 and a 52-week low of $19.06.
In the last year, Dicerna Pharmaceuticals(DRNA) shares hit a 52-week high of $40.14 and a 52-week low of $19.06.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.